Therapy Areas
18 January 2018 - - The US Food and Drug Administration has accepted the biologics license application from Holzkirchen, Germany-based biosimilar medicines specialist Sandoz, a Novartis division, submitted under the 351 (k) pathway, for proposed bios...
18 January 2018 - - The Woodbury, New York-based pancreatic research funding organization Lustgarten Foundation funded USD 22m in 2017 as part of its commitment to invest USD 40m by the end of 2018, the Foundation said.
In addition to funding ...
18 January 2018 - - Washington, DC-based immuno-oncology biotechnology company GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) has appointed Geoffrey B. Davis to its board of directors, effective immediately, the company said.
Davis ...
18 January 2018 - - Vancouver, British Columbia-based prostate cancer treatment developer ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) has closed the second tranche of its brokered equity offering, raising an additional USD 4m from a fund managed by Om...
18 January 2018 - United States-based Merck's Keytruda (pembrolizumab) in combination with pemetrexed (Alimta) plus platinum chemotherapy has improved overall survival and progression-free survival of a certain type of lung cancer patients in a ...
18 January 2018 - Moleculin Biotech Inc, (NASDAQ: MBRX), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, has added Dr Jorge Cortes and Dr Elihu Estey to its Science Advisory Board, it was reported ye...
18 January 2018 - Medical device company International Biophysics Corporation said on Wednesday that it has passed the US FDA's 510k clearance for their FloPump 32 centrifugal disposable heart pump, lowering healthcare cost in the market.The com...